еНаука - преглед

Преглед према Аутор Manojlovic, Nebojsa S

Приказ резултата 1 до 19 од 19
ГодинаНасловАутор(и)Тип резултатаМп-кат.
2016A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancerKim, Tae Won; ...; Manojlovic, Nebojsa S; ...; (broj, koautora 16)Научни чланак
21M21 - Рад у врхунском међ. часопису
2019A phase II, randomized, double-blind, placebo-controlled trial evaluating efficacy and safety of namodenoson (CF102), an A(3) adenosine receptor agonist (A(3)AR), as a second-line treatment in patients with Child-Pugh B (CPB) advanced hepatocellular carciStemmer, Salomon M; Manojlovic, Nebojsa S; ...; Natosevic, Sladjana; ...; (broj, koautora 20)Конференцијски рад
Мп категорија ће бити приказана накнадно.
2002Age, sex, primary tumor site and degree of tumor differentiation as prognostic factors in patients with Dukes c stage colon cancer receiving adjuvant treatmentManojlovic, Nebojsa S; Babic, DraganaКонференцијски рад
Мп категорија ће бити приказана накнадно.
2002Anti Helicobacter pylori immune response in patients with gastric cancer, gastric lymphoma, gastritis and duodenal ulcerManojlovic, Nebojsa S; Babic, Dragana; Filipovic-Ljeskovic, Ivana M; Pilcevic, Dijana RКонференцијски рад
Мп категорија ће бити приказана накнадно.
2016Association of ECOG performance status with efficacy in patients receiving panitumumab with best supportive care (BSC) vs BSC alone for chemorefractory metastatic colorectal cancerVrdoljak, Eduard; ...; Kusic, Zvonko; ...; Manojlovic, Nebojsa S; ...; (broj, koautora 16)Конференцијски рад
Мп категорија ће бити приказана накнадно.
2008Capecitabine cardiotoxicity - Case reports and literature reviewManojlovic, Nebojsa S; Babic, Dragana; Stojanovic, Snezana; Filipovic, Ivana; Doder, RadojeНаучни чланак
23M23 - Рад у међ. часопису
2018Final Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal CancerKim, Tae Won; Elme, Anneli; Park, Joon Oh; Udrea, Anghel Adrian; Kim, Sun Young; Ahn, Joong Bae; Valencia, Ricardo Villalobos; Krishnan, Srinivasan; Manojlovic, Nebojsa S; Guan, Xuesong;
Lofton-Day, Catherine; Jung, A Scott; Vrdoljak, Eduard;
Научни чланак
21M21 - Рад у врхунском међ. часопису
2016Final results from a phase III trial evaluating panitumumab (pmab) plus best supportive care (BSC) vs BSC in chemorefractory wild-type (WT) KRAS exon 2 and WT RAS metastatic colorectal cancer (mCRC).Kim, Tae Won; ...; Kusic, Zvonko; ...; Manojlovic, Nebojsa S; ...; (broj, koautora 16)Конференцијски рад
Мп категорија ће бити приказана накнадно.
2021Namodenoson in Advanced Hepatocellular Carcinoma and Child-Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical TrialStemmer, Salomon M; Manojlovic, Nebojsa S; ...; Natosevic, Sladjana; ...; (broj, koautora 21)Научни чланак
21M21 - Рад у врхунском међ. часопису
2016Persistent prevention of CIPN using calmangafodipir (Pled Ox): Results from a placebo-controlled randomized phase II study (PLIANT) in patients with metastatic colorectal cancer (mCRC).Glimelius, Bengt; Manojlovic, Nebojsa S; Pfeiffer, Per; Mosidze, Baadur; Petrova-Kurteva, Galina; Karlberg, Mia; Mahalingam, Devalingam; Bengtson, Marie; Nasstrom, JacquesКонференцијски рад
Мп категорија ће бити приказана накнадно.
2018Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx((R))): a placebo-controlled randomised phase II study (PLIANT)Glimelius, Bengt; Manojlovic, Nebojsa S; Pfeiffer, Per; Mosidze, Baadur; Kurteva, Galina; Karlberg, Mia; Mahalingam, Devalingam; Buhl, Jensen Peter; Kowalski, Jan; Bengtson, Marie;
Nittve, Malin; Nasstrom, Jacques;
Научни чланак
22M22 - Рад у истакнутом међ. часопису
2018Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancerVan, Cutsem Eric; Hidalgo, Manuel; Canon, Jean-Luc; Macarulla, Teresa; Bazin, Igor; Poddubskaya, Elena; Manojlovic, Nebojsa S; Radenkovic, Dejan V; Verslype, Chris; Eric, Raymond;
Cubillo, Antonio; Schueler, Armin; Zhao, Charles; Hammel, Pascal;
Научни чланак
21M21 - Рад у врхунском међ. часопису
2015Phase II randomized trial of MEK inhibitor pimasertib or placebo combined with gemcitabine in the first-line treatment of metastatic pancreatic cancer.Van, Cutsem Eric; Hidalgo, Manuel; Bazin, Igor; Canon, Jean-Luc; Poddubskaya, Elena; Manojlovic, Nebojsa S; Milella, Michele; Radenkovic, Dejan V; Verslype, Chris; Guo, Wei;
Damstrup, Lars; Hammel, Pascal;
Конференцијски рад
Мп категорија ће бити приказана накнадно.
2004Radiation-induced rectal ulcer - Prognostic factors and medical treatmentManojlovic, Nebojsa S; Babic, DraganaНаучни чланак
22M22 - Рад у истакнутом међ. часопису
2010Relevant: Prospective Evaluation of Efficacy and Safety of Bevacizumab Therapy in Metastatic Colorectal Carcinoma; Interim Analysis of Resecatability RateRadic, S; Markovic, M; Kovcin, Vladimir N; Andric, Zoran G; Manojlovic, Nebojsa S; Jovanovic, Dusan; Nikolic, Ivan V  ; Pantelic, Aleksandra; Popov, Ivan PКонференцијски рад
Мп категорија ће бити приказана накнадно.
2022Seroreactivity against Helicobacter pylori VacA, 50 kDa, and 30 kDa along with alarm features may improve the diagnostic approach to uninvestigated dyspepsia - a pilot studyManojlovic, Nebojsa S; Tufegdzic, Ivana Z; Ristanovic, Elizabeta S; Bokonjic, Dubravko RНаучни чланак
23M23 - Рад у међ. часопису
2022Simultaneous and alternative IgG seroreactivity against Helicobacter pylori antigens VacA, 30 kDa and 50 kDa is a better biomarker approach for the outcome of infection than VacA and 50 kDa aloneManojlovic, Nebojsa S; Tufegdzic, Ivana Z; Ristanovic, Elizabeta S; Bokonjic, Dubravko RНаучни чланак
23M23 - Рад у међ. часопису
2004Systemic humoral anti-Helicobacter pylori immune response in patients with gastric malignancies and benign gastroduodenal diseaseManojlovic, Nebojsa S; Nikolic, M; Pilcevic, Dijana R; Josifovski, Jeremija J; Babic, DraganaНаучни чланак
22M22 - Рад у истакнутом међ. часопису
2011The Impact of Capecitabine Dose Modification to Duration of Treatment in Patients with Metastatic Colorectal Cancer - First Results From Axiom TrialKovcin, Vladimir N; Manojlovic, Nebojsa S; Jovanovic, Dusan; Vrbic, Svetislav; Andric, Zoran G; Nikolic, Ivan V  ; Pantelic, Aleksandra; Ursulovic, Tamara BКонференцијски рад
Мп категорија ће бити приказана накнадно.